Sign in

CIK 0000946644

  • Non-accelerated filer
  • Smaller reporting company

AIM ImmunoTech Inc.

Sign in to watch
Ticker
AIM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
520845822
Phone
+1 352-448-7797
Business address
2117 SW HIGHWAY 484, OCALA, FL, 32801
Former names
AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
  1. 4 Conversion Chief Science/Medical Officer acquired 85,000 shares (conversion)
  2. 4 Conversion Exec. Vice Chairman/CEO/Pres. acquired 552,500 shares (conversion)
  3. 4 Conversion CFO acquired 85,000 shares (conversion)
  4. 4 Other acquisition Director acquired 108,608 shares (other)
  5. 4 Other acquisition Director acquired 108,608 shares (other)
  6. 4 Open-market buy Exec. Vice Chairman/CEO/Pres. bought 13,400 shares at $0.18 ($2,352)
  7. 4 Option exercise Director acquired 200,040 shares (option exercise)
  8. 4 Option exercise Director acquired 200,040 shares (option exercise)
  9. 4 Option exercise Sr. VP of Operations acquired 50,010 shares (option exercise)
  10. 4 Option exercise Chief Science/Medical Officer acquired 50,010 shares (option exercise)
  11. 4 Option exercise Dir Govt Relations/Sectry acquired 90,018 shares (option exercise)
  12. 4 Option exercise Exec. Vice Chairman/CEO/Pres. acquired 325,065 shares (option exercise)
  13. 4 Option exercise CFO acquired 50,010 shares (option exercise)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 10 of 31 · 615 filings